Advertisement
Advertisement
GALT
Galectin Therapeutics Inc.
4.05
USDSponsored
-0.09
-2.17%
Sep 23, 15:59 UTC -4
Closed
After-Market
4.01
-0.04
-0.91%
Galectin Therapeutics Inc. Financial Snapshot
| Market Cap | 404.71M |
| Beta | 0.38 |
| Earnings Per Share (EPS) | -0.43 |
| Price-to-Book (P/B) Ratio | -- |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | -100.62% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -- |
| Current Ratio | 0.10% |
| Free Cash Flow | -6.30M |
